148 related articles for article (PubMed ID: 238137)
1. Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats.
Bläsig J; Herz A; Gramsch C
Naunyn Schmiedebergs Arch Pharmacol; 1975; 286(4):325-36. PubMed ID: 238137
[TBL] [Abstract][Full Text] [Related]
2. Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine.
Elchisak MA; Rosecrans JA
Neuropharmacology; 1979 Feb; 18(2):175-82. PubMed ID: 571053
[No Abstract] [Full Text] [Related]
3. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
Bläsig J; Papeschi R; Herz A
Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
[No Abstract] [Full Text] [Related]
4. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-chronic morphine administration.
Theiss P; Papeschi R; Herz A
Eur J Pharmacol; 1975 Dec; 34(2):263-71. PubMed ID: 791659
[TBL] [Abstract][Full Text] [Related]
5. The effects of acute and chronic administration of morphine on the turnover of brain and adrenal catecholamines in rats.
Guaza C; Torrellas A; Borrell S; Borrell J
Psychopharmacology (Berl); 1980; 68(1):43-9. PubMed ID: 6104838
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
Kovács GL; Acsai L; Tihanyi A; Telegdy G
Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
[TBL] [Abstract][Full Text] [Related]
7. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
Herz A; Bläsig J; Papeschi R
Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
[No Abstract] [Full Text] [Related]
8. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
Etemadzadeh E
J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
[TBL] [Abstract][Full Text] [Related]
9. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
Iwamoto ET; Loh HH; Way EL
J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
[TBL] [Abstract][Full Text] [Related]
10. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
Attila LM; Ahtee L
Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
[TBL] [Abstract][Full Text] [Related]
11. Brain catecholamine metabolites and behavior in morphine withdrawal.
Swann AC; Elsworth JD; Charney DS; Jablons DM; Roth RH; Redmond DE; Maas JW
Eur J Pharmacol; 1982 Dec; 86(2):167-75. PubMed ID: 6297931
[TBL] [Abstract][Full Text] [Related]
12. Central serotonergic mechanisms and development of morphine dependence.
Blasig J; Papeschi R; Gramsch C; Herz A
Drug Alcohol Depend; 1976 Feb; 1(3):221-39. PubMed ID: 138583
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
15. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of certain mechanisms of morphine addiction.
Ovcharov R; Bantoutova I; Kobourova K
Acta Physiol Pharmacol Bulg; 1976; 2(2):68-74. PubMed ID: 1035029
[TBL] [Abstract][Full Text] [Related]
17. Drugs affecting brain dopamine interfere with the effect of Z-prolyl-D-leucine on morphine withdrawal.
Kovács GL; Telegdy G; Hódi K
Pharmacol Biochem Behav; 1984 Sep; 21(3):345-8. PubMed ID: 6541792
[TBL] [Abstract][Full Text] [Related]
18. Effects of morphine on the turnover of brain catecholamines and serotonin in rats-acute morphine administration.
Papeschi R; Theiss P; Herz A
Eur J Pharmacol; 1975 Dec; 34(2):253-61. PubMed ID: 791658
[TBL] [Abstract][Full Text] [Related]
19. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
Fuchs V; Coper H
Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
[TBL] [Abstract][Full Text] [Related]
20. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
Attila LM; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):201-7. PubMed ID: 6541759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
